| 000 | 01723 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514034503.0 | ||
| 264 | 0 | _c20020618 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMoa003069 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerl, Trish M | |
| 245 | 0 | 0 |
_aIntranasal mupirocin to prevent postoperative Staphylococcus aureus infections. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJun 2002 |
||
| 300 |
_a1871-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntibiotic Prophylaxis |
| 650 | 0 | 4 |
_aCross Infection _xprevention & control |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMupirocin _xtherapeutic use |
| 650 | 0 | 4 |
_aNose _xmicrobiology |
| 650 | 0 | 4 | _aOintments |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xprevention & control |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xisolation & purification |
| 650 | 0 | 4 |
_aSurgical Wound Infection _xprevention & control |
| 700 | 1 | _aCullen, Joseph J | |
| 700 | 1 | _aWenzel, Richard P | |
| 700 | 1 | _aZimmerman, M Bridget | |
| 700 | 1 | _aPfaller, Michael A | |
| 700 | 1 | _aSheppard, Deborah | |
| 700 | 1 | _aTwombley, Jennifer | |
| 700 | 1 | _aFrench, Pamela P | |
| 700 | 1 | _aHerwaldt, Loreen A | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 346 _gno. 24 _gp. 1871-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa003069 _zAvailable from publisher's website |
| 999 |
_c11958738 _d11958738 |
||